RxDoctor Payments Data

Charles Whittle

Optometrist · Tahlequah, OKNPI 1427304799

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $27,460 of the $28,007 with a category attached, or 98.0%. Optovue, Inc. accounts for 98.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $27,534 and has fallen 99.0% since, to $272 in 2025. Among optometrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,007in general payments, 2019–2025

Across 12 payments — averaging $2333.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optovue, Inc.$27K
  • Lumibird Medical Inc.$274
  • Harrow Eye, LLC$115
  • Johnson & Johnson Vision Care, Inc.$41
  • Spark Therapeutics, Inc.$37
  • Glaukos Corporation$25
  • plus $55 from 3 others

What the payments were for

  • Speaking & faculty fees$27,46098%
  • Food & beverage$5472%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,007 in reported general payments places this provider in the 95th percentile of 714 optometrist providers in Oklahoma.

See all optometrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$5,666
Medicare patients
48
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost24$118

Paid to pharmacies, not to this prescriber.

Other optometrist in Tahlequah

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →